Stay updated on Nivolumab & Cabozantinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab & Cabozantinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial page.

Latest updates to the Nivolumab & Cabozantinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial page
- Check6 days agoChange DetectedUpdated page copy notes that PubMed publications are automatically filled in from a public database and adds the revision label v3.3.2. The previous PubMed-related wording has been replaced with updated language indicating automatic PubMed linkage and the older revision label v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check13 days agoChange DetectedAdded a new publication citation Grimm MO et al. in Publications; removed an administrative notice about government funding and NIH operations.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedNo significant updates to the study design, objectives, or results were detected. The changes appear to be routine updates to the list of participating sites.SummaryDifference0.2%

- Check56 days agoChange DetectedAdds a government funding lapse notice and updated operating-status references, and upgrades the version from v3.1.0 to v3.2.0.SummaryDifference2%

- Check63 days agoChange DetectedUpdated the page version from v3.0.2 to v3.1.0; previous version tag removed and new version tag added.SummaryDifference0.1%

- Check78 days agoChange DetectedRevision updated to v3.0.2 and Back to Top removed; no core content or critical information is affected.SummaryDifference0.1%

Stay in the know with updates to Nivolumab & Cabozantinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab & Cabozantinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial page.